ArticleFrontiers in bioengineering and biotechnology2023

Development of tetracycline-modified nanoparticles for bone-targeted delivery of anti-tubercular drug.

Qiuzhen Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.